Literature DB >> 29232009

Effect of the Wnt/β-catenin signaling pathway on apoptosis, migration, and invasion of transplanted hepatocellular carcinoma cells after transcatheter arterial chemoembolization in rats.

Bao-Ming Wang1, Nuo Li2.   

Abstract

This study aims to investigate the influence of the Wnt/β-catenin signaling pathway on apoptosis, migration, and invasion of transplanted hepatocellular carcinoma (HCC) cells after transcatheter arterial chemoembolization (TACE) in rat models. A total of 80 rats were grouped into sham, TACE, Wnt-C59, and TACE + Wnt-C59 groups (n = 20). Ten days after model establishment, 10 rats in each group were executed to perform pathological examination and follow-up experiment, and the remaining 10 rats in each group were reared to observe the survival condition. RT-qPCR and Western blotting were applied to determine the expressions of Wnt1, β-catenin, cyclin D1, c-met, vimentin, E-cadherin, and vascular endothelial growth factor (VEGF). ELISA was performed to measure the serum alpha-fetoprotein (AFP) content of rats. Flow cytometry was used to evaluate cell apoptosis rate and transwell assay to examine cell migration and invasion. Compared with the TACE group, the Wnt-C59 and TACE + Wnt-C59 groups showed increased apoptosis and survival time (the TACE + Wnt-C59 group > the Wnt-C59 group). Compared with the sham group, the TACE + Wnt-C59 groups showed decreased cancer tissue weight and expressions of Wnt1, β-catenin, cyclin D1, vimentin, c-met, and VEGF, but increased E-cadherin expression. Compared with the TACE group, the Wnt-C59 and TACE + Wnt-C59 groups showed decreased AFP level, migration, and invasion (the TACE + Wnt-C59 group < the Wnt-C59 group). These findings indicate inhibition of the Wnt/β-catenin signaling pathway improves therapeutic effect on TACE via suppressing migration, invasion, and promoting apoptosis of transplanted HCC cells in rats.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Wnt/β-catenin signaling pathway; apoptosis; invasion; migration; prognosis; transcatheter arterial chemoembolization; transplanted hepatocellular carcinoma

Mesh:

Substances:

Year:  2018        PMID: 29232009     DOI: 10.1002/jcb.26576

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Overexpressed sFRP3 exerts an inhibitory effect on hepatocellular carcinoma via inactivation of the Wnt/β-catenin signaling pathway.

Authors:  Long Fang; Chun Gao; Ru-Xue Bai; Hui-Fen Wang; Shi-Yu Du
Journal:  Cancer Gene Ther       Date:  2020-09-26       Impact factor: 5.987

Review 2.  Long Non-coding RNA ZFPM2-AS1: A Novel Biomarker in the Pathogenesis of Human Cancers.

Authors:  Gabriel B K Sasa; Cheng Xuan; Guoliang Lyu; Xianfeng Ding; Fang Meiyu
Journal:  Mol Biotechnol       Date:  2022-01-31       Impact factor: 2.695

3.  Apoptosis of mesenchymal stem cells is regulated by Rspo1 via the Wnt/β-catenin signaling pathway.

Authors:  Xiao-Xia Cheng; Qiao-Yan Yang; Yong-Li Qi; Zhi-Zhen Liu; Dan Liu; Sheng He; Li-Hong Yang; Jun Xie
Journal:  Chronic Dis Transl Med       Date:  2019-03-19

4.  Studying the variations in differently expressed serum proteins of Hainan black goat during the breeding cycle using isobaric tags for relative and absolute quantitation (iTRAQ) technology.

Authors:  Rui Hua; Lu Zhou; Haiwen Zhang; Hui Yang; Wenchuan Peng; Kebang Wu
Journal:  J Reprod Dev       Date:  2019-07-14       Impact factor: 2.214

5.  Long Noncoding RNA ZFPM2-AS1 Knockdown Restrains the Development of Retinoblastoma by Modulating the MicroRNA-515/HOXA1/Wnt/β-Catenin Axis.

Authors:  Xueman Lyv; Fei Wu; Hong Zhang; Jia Lu; Lina Wang; Yunhai Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

6.  Transcatheter arterial chemoembolization combined with Hippo/YAP inhibition significantly improve the survival of rats with transplanted hepatocellular carcinoma.

Authors:  Yi Quan; Zhi Li; Kangshun Zhu; Jundi Liang
Journal:  Lipids Health Dis       Date:  2021-07-25       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.